Sales Growth YoY (Last 12 Months): Immunocore Holdings plc (IMCR)

Public company logo of Immunocore Corp (IMCR)

Immunocore Holdings plc is scaling cancer immunotherapy through partnerships with pharmaceutical behemoths. The technology stack has been enhanced with synthesis automation, although final tests remain the responsibility of physicians. The current year-over-year revenue growth (TTM) confirms this trend, where the parameter equals 13.20. This trend is driven by the market launch of targeted drugs, which are currently in a phase of active commercial growth.

Immunocore (IMCR) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Immunocore (IMCR) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Immunocore Holdings plc
Product sample of immunocore.com

The scale of Immunocore Holdings plc (IMCR) expansion in the field of cancer immunotherapy and the effectiveness of its strategic alliances are reflected in the TTM revenue growth. This metric measures the percentage change in total sales over the last 12 months relative to the previous year, representing the market consensus on the business's ability to scale the commercialization of the ImmTAX platform and strengthen its fundamental resilience.

Competitors of Immunocore Holdings plc (IMCR)

Sales Growth YoY (TTM) NantKwest IBRX|JANX - Sales Growth YoY (Last Twelve Months)|RCUS (arcusbio.com) - Sales Growth YoY (Last 12 Months)|Zymeworks Biopharmaceuticals (ZYME) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Tango Pharma (TNGX)|Revenue Growth YoY (Last 12 Months) IOVA|IMTX - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)